The Prognosis of Migraine and Tension-Type Headache in Children and Adolescents
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04623203 |
|
Recruitment Status :
Recruiting
First Posted : November 10, 2020
Last Update Posted : November 10, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Children, Only Headache, Migraine Headache, Tension | Other: No intervention |
| Study Type : | Observational [Patient Registry] |
| Estimated Enrollment : | 2000 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Target Follow-Up Duration: | 2 Years |
| Official Title: | The Prognosis of Migraine and Tension-Type Headache in Children and Adolescents |
| Actual Study Start Date : | November 22, 2018 |
| Estimated Primary Completion Date : | November 30, 2020 |
| Estimated Study Completion Date : | December 30, 2021 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
children with migraine
Children that were diagnosed at the neurology clinic with migraine at the years 2007-2010. A follow up visit at 2020 of their current headache condition.
|
Other: No intervention
No intervention |
|
children with TTH
children that were diagnosed at the neurology clinic with TTH at the years 2007-2010. A follow up visit at 2020 of their current headache condition.
|
Other: No intervention
No intervention |
- Headache diagnosis according to the ICHD-3 criteria [ Time Frame: 10 years from initial diagnosis ]The diagnosis of headache episodes at follow-up according to the ICHD-3 criteria; either Migraine or TTH.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 5 Years to 18 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Diagnosis of migraine or TTH headache according to the ICHD-3 criteria.
- Can describe the current headache status.
Exclusion Criteria:
* Secondary headaches.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04623203
| Contact: jacob Genizi, MD | 972-4-8359662 | genizij@gmail.com |
| Israel | |
| Bnai Zion Medical Center | Recruiting |
| Haifa, Israel, 3104802 | |
| Contact: Jacob Genizi, MD 972-4-8359662 genizij@gmail.com | |
| Principal Investigator: | Jacob GENIZI | Bnai Zion Medical Center |
| Responsible Party: | Jacob.genizi, Manager pediatric neurology unit, Bnai Zion Medical Center |
| ClinicalTrials.gov Identifier: | NCT04623203 |
| Other Study ID Numbers: |
BNZ 109-18 |
| First Posted: | November 10, 2020 Key Record Dates |
| Last Update Posted: | November 10, 2020 |
| Last Verified: | November 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Plan Description: | Not yer decided how |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Headache Migraine Tension Type Headache Adolescents Outcome |
|
Migraine Disorders Tension-Type Headache Headache Headache Disorders, Primary Headache Disorders |
Brain Diseases Central Nervous System Diseases Nervous System Diseases Pain Neurologic Manifestations |

